Literature DB >> 30366040

Genomic analysis of racial differences in triple negative breast cancer.

Chang-Sheng Chang1, Eiko Kitamura1, Joan Johnson1, Roni Bollag1, Lesleyann Hawthorn2.   

Abstract

Triple negative breast cancer (TNBC) is more prevalent in African Americans (AAs), has a more aggressive clinical course including a higher mortality rate and an increased occurrence of metastases. This study was designed to determine if racial differences at the molecular level might explain the more aggressive phenotype in AAs. Mutation profiling, was performed on 51 AA and 77 CA tumor/ normal pairs. Transcript expression analysis was performed on 35AA and 37CA. Genes with high frequency mutation rates such as MUC4 and TP53 were common to both racial populations, however genes that were less frequently mutated differed between the races suggesting that those cause the more aggressive nature of TNBC in AA women. JAK-Stat and HER2 signaling were unique to the AA and PTEN and mTOR were unique to the CA profiles. Many pathways identified by the mutational profiles were predicted to be down-regulated by the transcript expression profiles.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30366040     DOI: 10.1016/j.ygeno.2018.10.010

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  8 in total

1.  Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.

Authors:  Tess O'Meara; Anton Safonov; David Casadevall; Tao Qing; Andrea Silber; Brigid Killelea; Christos Hatzis; Lajos Pusztai
Journal:  Breast Cancer Res Treat       Date:  2019-02-06       Impact factor: 4.872

2.  Assessing Real-World Racial Differences Among Patients With Metastatic Triple-Negative Breast Cancer in US Community Practices.

Authors:  Ruoding Tan; Lourenia Cassoli; Ying Yan; Vincent Shen; Bann-Mo Day; Edith P Mitchell
Journal:  Front Public Health       Date:  2022-05-24

Review 3.  Molecular and Cellular Factors Associated with Racial Disparity in Breast Cancer.

Authors:  Manish Charan; Ajeet K Verma; Shahid Hussain; Swati Misri; Sanjay Mishra; Sarmila Majumder; Bhuvaneswari Ramaswamy; Dinesh Ahirwar; Ramesh K Ganju
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

4.  Distinguishing Kawasaki Disease from Febrile Infectious Disease Using Gene Pair Signatures.

Authors:  Jiayong Zhong; Qingsheng Huang; Yanfei Wang; Huan Gao; Hongling Jia; Jun Fan; Huiying Liang
Journal:  Biomed Res Int       Date:  2020-04-26       Impact factor: 3.411

Review 5.  Evaluating the promise of inclusion of African ancestry populations in genomics.

Authors:  Amy R Bentley; Shawneequa L Callier; Charles N Rotimi
Journal:  NPJ Genom Med       Date:  2020-02-25       Impact factor: 8.617

Review 6.  Cancer health disparities in racial/ethnic minorities in the United States.

Authors:  Valentina A Zavala; Paige M Bracci; John M Carethers; Luis Carvajal-Carmona; Nicole B Coggins; Marcia R Cruz-Correa; Melissa Davis; Adam J de Smith; Julie Dutil; Jane C Figueiredo; Rena Fox; Kristi D Graves; Scarlett Lin Gomez; Andrea Llera; Susan L Neuhausen; Lisa Newman; Tung Nguyen; Julie R Palmer; Nynikka R Palmer; Eliseo J Pérez-Stable; Sorbarikor Piawah; Erik J Rodriquez; María Carolina Sanabria-Salas; Stephanie L Schmit; Silvia J Serrano-Gomez; Mariana C Stern; Jeffrey Weitzel; Jun J Yang; Jovanny Zabaleta; Elad Ziv; Laura Fejerman
Journal:  Br J Cancer       Date:  2020-09-09       Impact factor: 9.075

7.  The TP63 Gene Polymorphism rs17506395 is Associated with Early Breast Cancer in Cameroon.

Authors:  Arnol T Z Tiofack; Gustave Simo; Elvis Ofon; Esther Dina-Bell; Chancelin M Kamla; Sidonie N Ananga; Tchamfong Roger; Theophile N Nana; Charlotte T Ngeufack; Adamou Fewou; Samuel Takongmo; Smiths Lueong
Journal:  Asian Pac J Cancer Prev       Date:  2020-08-01

8.  JCGA: the Japanese version of the Cancer Genome Atlas and its contribution to the interpretation of gene alterations detected in clinical cancer genome sequencing.

Authors:  Masakuni Serizawa; Maki Mizuguchi; Kenichi Urakami; Takeshi Nagashima; Keiichi Ohshima; Keiichi Hatakeyama; Sumiko Ohnami; Shumpei Ohnami; Koji Maruyama; Tadashi Ashizawa; Akira Iizuka; Yasue Horiuchi; Akane Naruoka; Hirotsugu Kenmotsu; Yasuto Akiyama; Ken Yamaguchi
Journal:  Hum Genome Var       Date:  2021-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.